A randomized controlled trial of pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in end-stage renal disease patients on hemodialysis
| dc.contributor.author | شهيد "محمد بكر" "محمد رشدي" معلا | |
| dc.contributor.author | اسامه خالد جبر سوالمه | |
| dc.date.accessioned | 2021-09-08T11:37:53Z | |
| dc.date.available | 2021-09-08T11:37:53Z | |
| dc.date.issued | 2017-05-09 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11888/16191 | |
| dc.language.iso | en | en_US |
| dc.supervisor | Basama Damiri , Souad Belkabir , Ramzi Shawahna , Mujahed Shraim , Zakaria Hamdan | en_US |
| dc.title | A randomized controlled trial of pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in end-stage renal disease patients on hemodialysis | en_US |
| dc.type | Graduation project | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A randomized controlled trial of pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in end-stage renal disease patients on hemodialysis.pdf
- Size:
- 73.55 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: